Grissinger Michael — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Grissinger Michael has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
Profile
Michael Grissinger is a corporate director who, according to the latest SEC filing dated 2026-06-17, serves as a director of Aprea Therapeutics, Inc. The SEC filing context identifies him specifically in the director role for Aprea Therapeutics, with no additional biographical details provided in the filing summary. Public sources within this context do not reveal further education, prior positions, or achievements beyond the board role.
Role
Insider
Notability
25/100
Board memberships
Aprea Therapeutics, Inc.
Awards & honors
Director at Aprea Therapeutics, Inc. (as of 2026-06-17)
Michael Grissinger is a corporate director who, according to the latest SEC filing dated 2026-06-17, serves as a director of Aprea Therapeutics, Inc. The SEC filing context identifies him specifically in the director role for Aprea Therapeutics, with no additional biographical details provided in the filing summary. Public sources within this context do not reveal further educa…
How many SEC Form 4 filings has Grissinger Michael submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Grissinger Michael's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
